02:01 PM EDT, 03/18/2024 (MT Newswires) -- Leap Therapeutics ( LPTX ) on Monday filed registration with US Securities and Exchange Commission to sell common stock, preferred stock, warrants, debt securities, rights to purchase common and preferred stock, debt securities or units, and units, which it plans to offer from time to time.

The mixed-securities are expected to have an aggregate offering price of up to $200 million, the company said.

The company said it will retain broad discretion over the use of the net proceeds.

Price: 2.18, Change: -0.04, Percent Change: -1.58